改良LR-M标准能否提升CEUS LI-RADS对≤3cm小肝病灶的诊断效能?
该回顾性研究纳入179例HCC高危患者共194个≤3cm病灶,评估CEUS LI-RADS v2017及改良LR-M标准。将早期廓清时间修订为45秒可提高LR-5预测HCC的敏感度(P=.004)且特异度无显著下降(P=.118),同时改善LR-M预测非HCC恶性肿瘤的特异度(P=.001)且敏感度无显著下降(P=.094)。
要点
- ≤3cm病灶中,早期廓清时间改为45秒可提升LR-5诊断HCC的敏感度。
- 45秒标准下LR-M预测非HCC恶性肿瘤特异度提高,敏感度无显著下降。
- 以3分钟内作为明显廓清标准会降低LR-5特异度,临床需谨慎。
关键影像表现/征象
- 早期廓清时间修订为45秒后LR-5预测HCC的敏感度提高(P=.004),特异度无显著下降(P=.118)。
- 45秒标准使LR-M预测非HCC恶性肿瘤的特异度提高(P=.001),敏感度无显著下降(P=.094)。
- 以3分钟内作为明显廓清标准提高LR-5预测HCC敏感度(P<.001)但降低特异度(P=.009)。
- 3分钟明显廓清标准下LR-M预测非HCC恶性肿瘤特异度提高(P<.001)但敏感度降低(P=.027)。
诊断标准与关键数值
- LR-5预测HCC:早期廓清时间修订为45秒时敏感度提高(P=.004),特异度无显著下降(P=.118)。
- LR-M预测非HCC恶性肿瘤:早期廓清时间修订为45秒时特异度提高(P=.001),敏感度无显著下降(P=.094)。
- LR-5预测HCC:以3分钟内为明显廓清标准时敏感度提高(P<.001),特异度降低(P=.009)。
- LR-M预测非HCC恶性肿瘤:以3分钟内为明显廓清标准时特异度提高(P<.001),敏感度降低(P=.027)。
临床应用与阅片要点
- 对≤3cm高危病灶,采用45秒早期廓清标准可在不显著损失特异度下提高LR-5检出HCC的敏感度。
- 45秒标准同时改善LR-M对非HCC恶性肿瘤的特异度,有助于减少误判。
- 使用3分钟内明显廓清标准需权衡LR-5敏感度提升与特异度下降的风险。
局限性
- 本研究为单中心回顾性分析,结论需前瞻性多中心验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To assess the diagnostic performance of the contrast-enhanced ultrasound liver imaging reporting and data system (CEUS LI-RADS) version 2017 for small hepatic lesions of ≤3 cm before and after changing the LR-M criteria.
METHODS: We retrospectively analyzed the CEUS examination of 179 patients who were at high risk of hepatocellular carcinoma (HCC) with focal hepatic lesions ≤3 cm (194 lesions in total) and evaluated the diagnostic capability of the American College of Radiology and modified CEUS LI-RADS algorithms.
RESULTS: Revision of the early washout time to 45 seconds increased the sensitivity of LR-5 in predicting HCC (P = .004), with no significant decrease in specificity (P = .118). It also made better the specificity of LR-M in predicting non-HCC malignancies (P = .001), with no significant decrease in sensitivity (P = .094). However, using within 3 minutes as the criterion for marked washout time improved the LR-5 sensitivity (P < .001) but decreased its specificity (P = .009) in predicting HCC, whereas the specificity of LR-M in predicting non-HCC malignancies increased (P < .001), but the sensitivity decreased (P = .027).
CONCLUSIONS: CEUS LI-RADS (v2017) is a valid method for predicting HCC risk in high-risk patients. The diagnostic performance of LR-5 and LR-M could boost when the early washout time is revised to 45 seconds.
引用
- Huang, Wen, Wu, et al. Can Modifications of LR-M Criteria Improve the Diagnostic Performance of Contrast-Enhanced Ultrasound LI-RADS for Small Hepatic Lesions up to 3 cm? J Ultrasound Med. 2023. PMID: 37269201. doi:10.1002/jum.16267
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。